Evidence map›Paper›PMID 35218524›Full record

ArticleCerebellum (London, England)2023

Loss of Neuron Navigator 2 Impairs Brain and Cerebellar Development.

Andrea Accogli, Shenzhao Lu, Ilaria Musante, Paolo Scudieri, Jill A Rosenfeld, Mariasavina Severino, Simona Baldassari, Michele Iacomino, Antonella Riva, Ganna Balagura and 24 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Cerebellum (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Transcriptional profiling of extraocular motor neurons revealsbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Role of CPEBs in Learning and Memory.Journal of neurochemistry · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Adaptor protein Abelson interactor 1 in homeostasis and disease.Cell communication and signaling : CCS · 2024
    Review
  10. Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Identification of novel genes includingFrontiers in endocrinology · 2023
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 13 institutions in 4 countries.

Andrea Accogli *Division of Medical Genetics, Department of Specialized Medicine, McGill University, Montreal, Canada.
Shenzhao Lu *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Ilaria Musante *Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Paolo ScudieriUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Mariasavina SeverinoNeuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Simona BaldassariUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Michele IacominoUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Antonella RivaDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Ganna BalaguraUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Gianluca PiccoloDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Carlo MinettiDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Denis RobertoChild Neurology and Psychiatry Unit, System Medicine Department, Tor Vergata University of Rome, 00133, Rome, Italy.
Fan XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Razaali RazakTexas Childrens Hospital, Houston, TX, USA.
Emily LawrenceDepartment of Cardiology, Texas Childrens Hospital, Houston, USA.
Mohamed HusseinDepartment of Ophthalmology, Texas Childrens Hospital, Houston, USA.
Emmanuel Yih-Herng ChangRetina and Vitreous of Texas, Houston, TX, USA.
Michelle HolickTexas Childrens Hospital, Houston, TX, USA.
Elisa CalìDepartment of Neuromuscular Diseases, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Emanuela AlibertoCasa Di Cura La Madonnina, via Quadronno 29, 20122, Milano, Italy.
Rosalba De-SarroDepartment of Clinical and Experimental Medicine, Policlinic "G. Martino", University of Messina, 98100, Messina, Italy.
Antonio GambardellaDepartment of Medical and Surgical Sciences, Universita' Degli Studi "Magna Graecia" Viale Europa, 88100, CATANZARO, Italy.
Undiagnosed Diseases Network
SYNaPS Study Group
Lisa EmrickJan and Dan Duncan Neurological Research Institute, Texas Childrens Hospital, Houston, TX, 77030, USA.
Peter J A McCafferyInstitute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK.
Margaret Clagett-DameDepartment of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin, Madison, WI, 53706, USA.
Paul C MarcoglieseDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Seema R LalaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Federico ZaraUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Pasquale StrianoDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Vincenzo SalpietroDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy. v.salpietro@ucl.ac.uk.
Texas Children's Hospital · USIstituto Giannina Gaslini · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITBaylor College of Medicine · USUniversity of Genoa · ITCasa di Cura Columbus · ITMagna Graecia University · ITMcGill University · CANational Hospital for Neurology and Neurosurgery · GBUniversity of Aberdeen · GBUniversity of Messina · ITUniversity of Rome Tor Vergata · ITUniversity of Wisconsin–Madison · US

Funding

Pilot of New Technologies to Increase the Genomic Diagnosis of Undiagnosed Disease Network (UDN) PatientsU01HG007709 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI BACINO, CARLOS A., LEE, BRENDAN · 2014 to 2022
$14.3M
NHGRI NIH HHS U01 HG007709
6 · The paper itself

Abstract

Cerebellar hypoplasia and dysplasia encompass a group of clinically and genetically heterogeneous disorders frequently associated with neurodevelopmental impairment. The Neuron Navigator 2 (NAV2) gene (MIM: 607,026) encodes a member of the Neuron Navigator protein family, widely expressed within the central nervous system (CNS), and particularly abundant in the developing cerebellum. Evidence across different species supports a pivotal function of NAV2 in cytoskeletal dynamics and neurite outgrowth. Specifically, deficiency of Nav2 in mice leads to cerebellar hypoplasia with abnormal foliation due to impaired axonal outgrowth. However, little is known about the involvement of the NAV2 gene in human disease phenotypes. In this study, we identified a female affected with neurodevelopmental impairment and a complex brain and cardiac malformations in which clinical exome sequencing led to the identification of NAV2 biallelic truncating variants. Through protein expression analysis and cell migration assay in patient-derived fibroblasts, we provide evidence linking NAV2 deficiency to cellular migration deficits. In model organisms, the overall CNS histopathology of the Nav2 hypomorphic mouse revealed developmental anomalies including cerebellar hypoplasia and dysplasia, corpus callosum hypo-dysgenesis, and agenesis of the olfactory bulbs. Lastly, we show that the NAV2 ortholog in Drosophila, sickie (sick) is widely expressed in the fly brain, and sick mutants are mostly lethal with surviving escapers showing neurobehavioral phenotypes. In summary, our results unveil a novel human neurodevelopmental disorder due to genetic loss of NAV2, highlighting a critical conserved role of the NAV2 gene in brain and cerebellar development across species.

Indexed as

BrainNervous System MalformationsAnimalsCerebellumDevelopmental DisabilitiesFemaleHumansMiceNerve Tissue ProteinsNeuronsNav2 protein, mouseNerve Tissue ProteinsAxon elongation, Brain malformationCerebellar cortical dysplasiaCerebellar hypoplasiaNAV2Neuron migration

Identifiers

PMID35218524
PMCPMC9985553
OpenAlexW4214484597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.